Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

Consolidated Statement of Financial Position At 30 June 2012

Non-current assets
Intangible assets11225,872125,098
Property, plant and equipment1216,7207,721
Total non-current assets242,592132,819
Current assets
Trade and other receivables1672,11366,293
Cash and cash equivalents1732,43530,496
Total current assets161,829137,549
Total assets404,421270,368
Current liabilities
Trade and other payables18(79,863)(74,559)
Deferred and contingent consideration28(10,337)(500)
Current tax liabilities19(8,155)(5,391)
Total current liabilities(103,461)(88,952)
Non-current liabilities
Deferred and contingent consideration28(3,526)(13,555)
Employee benefit obligations21(363)
Deferred tax liabilities14(29,343)(13,443)
Total non-current liabilities(147,278)(83,083)
Total liabilities(250,739)(172,035)
Net assets153,68298,333
Issued share capital23869664
Share premium account122,64263,559
Hedging reserve(286)(294)
Foreign currency translation reserve(3,683)4,751
Merger reserve1,7701,770
Retained earnings32,37027,883
Total equity attributable to equity holders of the parent153,68298,333

The financial statements were approved by the Board of Directors on 4 September 2012 and are signed on its behalf by:

Ian Page
Chief Executive
4 September 2012

Simon Evans
Group Finance Director
4 September 2012

Company number: 3369634

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.